Cell & Gene Therapy LVV Webinar | From DNA to Therapy: Plasmid & LVV Insights | ProBio CDMO 04-22-2025 / Luffy Chen, Head of Plasmid PD and Production Dept., ProBio Join us on April 22ⁿᵈ for an exclusive webinar on Cell and Gene Therapy (CGT) development! Gain expert knowledge on optimizing plasmid and LVV production timelines, ensuring regulatory compliance, and navigating IND and BLA applications... Learn More
Therapeutic Antibody Biologics Webinar | Biologics CMC Regulatory, Process & Tech Transfer | ProBio CDMO 03-08-2025 / Tina Yu, Sr. Director of Regulatory Affairs Dept., ProBio As the biologics field rapidly evolves, mastering regulatory pathways, process development, and tech transfer is essential for success. Gain key insights to drive innovation and overcome challenges. Learn More
Therapeutic Antibody Antibody Discovery Webinar | Functional Antibody Lead Discovery & Engineering | ProBio CDMO 03-04-2025 / Derek Chen, Sr. Director, Antibody Drug Discovery Dept. ProBio Functional screening is the most crucial step for the early-stage therapeutic antibody discovery. Currently, most of antibody lead discovery strategy starts with screening for binders, followed by functional characterization with purified antibody. Learn More
Therapeutic Antibody Pre-clinical DMPK Study and Generation of Toolbox to Facilitate PK/ADA Analysis | ProBio CDMO 02-25-2025 / Derek Chen, Sr. Director, Antibody Drug Discovery Dept. Animal based DMPK analysis is a crucial component in pre-clinical study of drug candidate. Learn More
Therapeutic Antibody Antibody Engineering and Developablity Service | ProBio CDMO 06-04-2024 / Alex Chen, Head of ADD PM Dept., ProBio The functionality and developability properties of therapeutic antibodies are two major concerns in preclinical development. Addressing the optimization strategy in the discovery stage enables acquiring better antibody candidates before entering CMC. Learn More
Cell & Gene Therapy Strategies and Solutions for mRNA Therapeutics and Personalized Medicines | ProBio CDMO 05-23-2024 / Dr. Xiao Pan, Director of Platform R&D Dept. Learn More
Therapeutic Antibody Cost Reduction Strategies in Clinical Stage Process Optimization for Biologics | ProBio CDMO 05-14-2024 / Rubin Jiang, Director of Antibody Process Development & MSAT, ProBio Costly medicines are a burden for both individual patients and national budgets. The Prescription Drug Law within the Inflation Reduction Act (IRA) exemplifies efforts to make medicines more affordable. The production of biologics requires intricate manuf Learn More
Therapeutic Antibody Accelerated therapeutic antibody discovery via ProSpeed™ single B cell platform | ProBio CDMO 04-24-2024 / Dr. Derek Chen, Sr. Director, Biologics Discovery Dept. ProBio As of 2023, more than 100 Ab drugs have been approved by FDA, most of them were generated by hybridoma and phage library. However, as a newly emerged technology, single B cell approach contributed 20% of approved drug during the last four years. Learn More